The Nanomedicine Translation Advisory Board is a service that has been designed as the prime initiative to help the European nanomedicine community not to get lost in translation.
Apply to the TAB
About the nanomedTAB
The mission of the Nanomedicine Translation Advisory Board is to guide and promote innovative nanomedicine projects by providing free strategic advice, support and concrete recommendations. The ultimate mission of TAB is to facilitate access to clinical trials or the market uptake of promising projects supported.
The TAB aims at helping individual actors of the European nanomedicine community to translate their promising projects into innovative products for healthcare by providing a free advisory service based on the high-level experience of seasoned nanomedicine translation experts.
- Stage-gate service that offers free one-to-one advice sessions to the European nanomedicine community at any stage of their nanobiomedical endeavours. Duration and depth of the advisory service depends on the merit of each project to qualify for the different stages of the service.
- The content is driven by the needs each project brings, and tailored to the beneficiaries’ ultimate concerns and expectations. It may include topics such as R&D; process development, optimisation and scale-up; safety and quality control; clinical investigation; regulatory and reimbursement issues; intellectual property rights and licensing; business strategy, business modelling and development, funding strategies; networking, collaboration, commercialisation.
- Advice aims at responding to projects’ needs including access to clinical centres for first studies in patients, financial resources from investors and/or large companies to accelerate critical steps to market.
- Most promising projects will be eligible for further high value services such as showcase opportunities to clinical trial centres, investors and large companies. Special coaching sessions may be organised prior to showcasing events.
- The nature of the advice and recommendations to be provided is not binding, meaning that beneficiaries may or not follow advice and recommendations at their own discretion.
What the community is saying about us
My presence at the TAB-IN sessions was a great opportunity to discuss strategies and ideas with experts in the nanomedicine translation. As such, it is my strong belief that these sessions are very important to fill in the gap between academia and the industry. The experts were able to tackle the major issues regarding our project, identifying its major strengths and weaknesses, and the informal nature of the meeting allowed a fruitful discussion of strategies and ideas. The experts’ feedback helped us establish an order of priority for the upcoming tasks, thus setting us a guide to successfully develop our project. The local support from the organizing committee and the lovely Dublin sights also contributed to an overall positive experience.
To have the opportunity of presenting our project in the Stage I TAB-in session was exceptional and very stimulating. The advice we could get from high level experts in Pharma Development and Business was for us of extremely high value. We are, indeed, moving ahead with our idea in a more effective manner and are looking forward an active communication with our advisers. We believe this initiative is an essential instrument for helping academics and SMEs with a clear translational vocation
The participation on the TAB-In Sessions was very profitable. The consultants have shown me the potential pitfalls and the requisites my project has to meet in order to succeed. The experts also provided some interesting insight and ideas about how to attract investment and help important stakeholders to recognize our product and our technology as innovative and promising.
During the Stage I TAB-In session held in Dublin I had a chance to meet two enthusiastic, friendly and highly competent TAB experts. They appeared to be genuinely interested in my project story and rendered the 2-hour discussion pleasant and fully stimulating. During the discussion they posed highly relevant questions and carefully evaluated all answers. They specifically addressed some business opportunity and fund raising aspects and at the end of the meeting they gave factive suggestions regarding product exploitation and commercialization which will surely help us in further project development.
Our experience in Dublin during the first TAB-in session, has been without doubt very useful, as well as an experience that usually does not exist in the most cases of on-going academic scientific projects and of high value.
Currently, the LIPOCELL project is industrially driven, as it is directly funded by BIOPRAXIS company, as well as by CIBER-BBN network . Nevertheless, there are some business related issues, as well as some clinical aspects, that were not clear yet how to address them properly at the moment of the meeting with the TAB committee.
The TAB-in session board highlighted them after the presentation of the project and focused our attention on these critical issues. It is important and it is totally necessary that we keep in mind them during the progression of the project in the near future, if we want to succeed and arrive to the market in the best conditions for the developed nanomedicine.
Finally, we are currently working on these highlighted issues and we will be happy to get more expert advice from the TAB board if they consider it of interest
As a PhD student, it was a big challenge having the opportunity of presenting my idea at the TAB-In sessions. I have received very direct, precise and valuable feedback which helped me to better direct my work. The TAB-In session powered ideas into real projects and I couldn't be more proud of having this experience!
The TAB offered an invaluable opportunity to pitch the technology forward to a panel of experts in the field with varying and complementary expertise. Their insight and two-way discussion has been invaluable in developing a pathway for clinical development of our molecule, SAN101!
Adjuvatis is a startup recently founded which aims at developing fully metabolizable adjuvants and biodegradable, safe-by-design delivery systems. A developing project was submitted to the Nanomedicine Translation Advisory Board and selected for evaluation on October 2015. I was invited to present the project in Dublin a few days later. I was warmly welcomed by the group involved in ENATRANS support action. My project was presented to two experts in the field of bioresorbable materials, highly experienced in conducting business. This around 2 hours exchange was conducted in an open, curious and very encouraging mind! I received extremely relevant comments and advices. To create Adjuvatis, founder and I have benefit from two years of support which were very informative, but two hours of TAB experience have absolutely completed this initial training. My project has not passed the initial advisory stage, but for sure I’ll try my luck again!
The Dublin TAB-in session was very useful to better structure the next steps we should take in the project!
News and upcoming Events
Third cut-off date of the TAB
The cut-off date for the 3rd TAB-in Sessions, in Heraklion, Crete, has been anounced. Submit your projects untill the 31st of July and be the next project to join the 29 projects already being supported by the TAB in the road to Nanomedicine Translation.
TAB-In sessions in Basel
Projects selected in the 2nd cut-off will be invited to join 2-hours individual sessions with experts in Basel. The TAB-In Sessions are the entry point to the support service offered by the TAB.
Second cut-off date of the TAB
The TAB is already supporting 20 projects from different countries in Europe. Don’t miss out the opportunity to apply and benefit from TAB support as well!